SYNACT PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.8 SEK | -5.09% |
|
-3.41% | -22.99% |
| 23/04 | Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting | CI |
| 20/03 | Sweden's SynAct Pharma Names New CEO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNACT PHARMA AB | Other Biotechnology & Medical Research | -5.09% | -3.41% | -22.99% | -90.90% | -34.62% | 26.66M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- SYNACT Stock
- Charts SynAct Pharma AB
- Comparison Chart
